182 related articles for article (PubMed ID: 24456137)
1. Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer.
Sadasivam N; Johnson RJ; Owen RG
Br J Haematol; 2014 Jun; 165(5):584. PubMed ID: 24456137
[No Abstract] [Full Text] [Related]
2. Epstein-Barr virus-positive mucocutaneous ulcers as a manifestation of methotrexate-associated B-cell lymphoproliferative disorders.
Hashizume H; Uchiyama I; Kawamura T; Suda T; Takigawa M; Tokura Y
Acta Derm Venereol; 2012 May; 92(3):276-7. PubMed ID: 22293895
[No Abstract] [Full Text] [Related]
3. Epstein-Barr virus-positive mucocutaneous ulcer of the oral cavity: the importance of having a detailed clinical history to reach a correct diagnosis.
Attard AA; Praveen P; Dunn PJ; James GJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):e37-9. PubMed ID: 22769419
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-associated Epstein-Barr virus mucocutaneous ulcer: A case report and review of literature.
Ravi PY; Sigamani E; Jeelani Y; Manipadam MT
Indian J Pathol Microbiol; 2018; 61(2):255-257. PubMed ID: 29676371
[TBL] [Abstract][Full Text] [Related]
5. Oral eosinophilic ulcer, an Epstein-Barr virus-associated CD30+ lymphoproliferation?
Abdel-Naser MB; Tsatsou F; Hippe S; Knolle J; Anagnostopoulos I; Stein H; Zouboulis CC
Dermatology; 2011; 222(2):113-8. PubMed ID: 21464557
[TBL] [Abstract][Full Text] [Related]
6. [Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis].
Pastor-Nieto MA; Kilmurray LG; López-Chumillas A; O'Valle F; García-Del Moral R; Puig AM; Bautista P
Actas Dermosifiliogr; 2009 Mar; 100(2):142-6. PubMed ID: 19445880
[TBL] [Abstract][Full Text] [Related]
7. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.
Dojcinov SD; Venkataraman G; Raffeld M; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2010 Mar; 34(3):405-17. PubMed ID: 20154586
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
Maruani A; Wierzbicka E; Machet MC; Abdallah-Lotf M; de Muret A; Machet L
J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S69-71. PubMed ID: 17938029
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus?
Starkebaum G
J Rheumatol; 2001 Dec; 28(12):2573-5. PubMed ID: 11764198
[No Abstract] [Full Text] [Related]
10. EBV-positive Mucocutaneous Ulcer With Small Lymphocytic Infiltration Mimicking Nonspecific Ulceration.
Fujimoto M; Kaku Y; Hirata M; Usui S; Yamada Y; Haga H
Am J Surg Pathol; 2021 May; 45(5):694-700. PubMed ID: 33739792
[TBL] [Abstract][Full Text] [Related]
11. [Spontaneous regression of immunodeficiency associated plasmablastic lymphoma related to methotrexate after decrease of dosage].
García-Noblejas A; Velasco A; Cannata-Ortiz J; Arranz R
Med Clin (Barc); 2013 Jun; 140(12):569-70. PubMed ID: 23177304
[No Abstract] [Full Text] [Related]
12. Systemic EBV-Positive Methotrexate-Related Lymphoproliferative Disorder Associated With Skin Lesion Resembling EBV-Positive Mucocutaneous Ulcer: A Report of Two Cases.
Fujimoto M; Takai T; Okada M; Okuno A; Haga H
Am J Dermatopathol; 2021 Aug; 43(8):604-605. PubMed ID: 33606374
[No Abstract] [Full Text] [Related]
13. High prevalence of methotrexate use in patients with Epstein-Barr virus-positive mucocutaneous ulcer may cause confounding bias.
Ramia de Cap M; Michaels PD
Mod Pathol; 2021 Nov; 34(11):2084. PubMed ID: 33758325
[No Abstract] [Full Text] [Related]
14. Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
Curry JL; Prieto VG; Jones DM; Vega F; Duvic M; Diwan AH
J Cutan Pathol; 2011 Mar; 38(3):295-7. PubMed ID: 19889052
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous remission of methotrexate-associated lymphoproliferative disorder with Epstein-Barr virus type II latency.
Matsuzaki Y; Minakawa S; Sagara C; Takiyoshi N; Nakano H; Sawamura D
Eur J Dermatol; 2018 Oct; 28(5):693-694. PubMed ID: 30325313
[No Abstract] [Full Text] [Related]
16. Lymphoproliferative Disease After Pediatric Liver Transplant.
Özçay F
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):79-81. PubMed ID: 28302005
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-associated lymphoproliferative disorder arising in a patient with adult Still's disease.
Tanaka A; Shigematsu H; Kojima M; Sakashita H; Kusama K
J Oral Maxillofac Surg; 2008 Jul; 66(7):1492-5. PubMed ID: 18571037
[No Abstract] [Full Text] [Related]
18. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
Adams B; Lazarchick J; Medina AM; Willner IR; Neville B; Murphy E; Stuart R; Costa LJ
Am J Hematol; 2010 Aug; 85(8):627-9. PubMed ID: 20658594
[No Abstract] [Full Text] [Related]
19. CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
Hatachi S; Kunitomi A; Aozasa K; Yagita M
Mod Rheumatol; 2010 Oct; 20(5):500-5. PubMed ID: 20437072
[TBL] [Abstract][Full Text] [Related]
20. EBV-positive mucocutaneous ulcer in a patient with systemic lupus erythematosus.
Ritter CG; de David Cruz C; Zamboni S; Busato VB; da Silveira RG; Provenzi VO; Bredemeier M
Rheumatology (Oxford); 2020 Apr; 59(4):916. PubMed ID: 31497843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
